Investors Snag ACRS Even Cheaper Than Its Secondary Stock Offering
January 22, 2021 at 10:01 AM EST
Looking back to 2 days ago, Aclaris Therapeutics Inc (ACRS) priced a 5,483,714 share secondary stock offering at $17.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..